The vaccine induced significant CD4+ and CD8+ HIV-1 Gag-specific T-cell responses in a subset of participants and marginally significant decreases in the level of viremia during the analytic treatment interruption.
← all excerpts
Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial.
1
—
—